(S)-3-(Carboxyformamido)-2-(3-(carboxymethyl)ureido)propanoic Acid as a Novel PSMA Targeting Scaffold for Prostate Cancer Imaging

Citations

WEB OF SCIENCE

44
Citations

SCOPUS

48

초록

In an effort to seek novel agents targeting prostate-specific membrane antigen (PSMA), 16 ligands (L1-L16) with structural modifications in S1' binding pocket were synthesized and evaluated for PSMA inhibition. (S)-3-(Carboxyformamido)-2-(3-(carboxymethyl)ureido)propanoic acids proved to be potent PSMA ligands with K-i values ranging from 0.08 nM to 8.98 nM, which are in the range of or are higher in potency compared to previously published urea-based ligands. Computational docking was performed to study the binding mode of the two most potent ligands discovered. FITC-conjugated L14 could selectively stain PSMA(+) LNCaP cells over PSMA(-) PC3 cells. IRDye800CW conjugated L16 can effectively image tumors in a murine xenograft model of prostate cancer.

키워드

GLUTAMATE CARBOXYPEPTIDASE-IIUREA-BASED INHIBITORSMEMBRANE ANTIGENBIOLOGICAL EVALUATIONPRECLINICAL EVALUATIONRADIOLIGAND THERAPYGCPII INHIBITORSPETDESIGNAGENTS
제목
(S)-3-(Carboxyformamido)-2-(3-(carboxymethyl)ureido)propanoic Acid as a Novel PSMA Targeting Scaffold for Prostate Cancer Imaging
저자
Duan, XiaojiangLiu, FutaoKwon, HongmokByun, YoungjooMinn, IlCai, XuekangZhang, JingmingPomper, Martin G.Yang, ZhiXi, ZhenYang, Xing
DOI
10.1021/acs.jmedchem.9b02031
발행일
2020-04-09
유형
Article
저널명
Journal of Medicinal Chemistry
63
7
페이지
3563 ~ 3576